These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 21412282

  • 21. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
    Dong F, Wang L, Davis JJ, Hu W, Zhang L, Guo W, Teraishi F, Ji L, Fang B.
    Clin Cancer Res; 2006 Sep 01; 12(17):5224-30. PubMed ID: 16951242
    [Abstract] [Full Text] [Related]

  • 22. [Security of dual cancer-specific targeting vector and its cytotoxic effect when harbored].
    Wang J, Gu JF, Yang SY, Xiao T, Qi R, Sun LY, Liu XY.
    Ai Zheng; 2006 Apr 01; 25(4):385-92. PubMed ID: 16613667
    [Abstract] [Full Text] [Related]

  • 23. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.
    Cancer Gene Ther; 2006 Nov 01; 13(11):1011-22. PubMed ID: 16799468
    [Abstract] [Full Text] [Related]

  • 24. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Huang F, Ma B, Wang Y, Xiao R, Kong Y, Zhou X, Xia D.
    Cancer Biother Radiopharm; 2014 Dec 01; 29(10):403-11. PubMed ID: 25414976
    [Abstract] [Full Text] [Related]

  • 25. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M, Rodriguez-Madoz JR, Alzuguren P, Gomar C, Kramer MG, Kochanek S, Prieto J, Smerdou C, Qian C.
    Cancer Res; 2006 Feb 01; 66(3):1620-9. PubMed ID: 16452221
    [Abstract] [Full Text] [Related]

  • 26. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
    Liu XY, Qiu SB, Zou WG, Pei ZF, Gu JF, Luo CX, Ruan HM, Chen Y, Qi YP, Qian C.
    Mol Ther; 2005 Apr 01; 11(4):531-41. PubMed ID: 15771956
    [Abstract] [Full Text] [Related]

  • 27. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
    Xiao T, Fan JK, Huang HL, Gu JF, Li LY, Liu XY.
    Cell Res; 2010 Mar 01; 20(3):367-78. PubMed ID: 19918267
    [Abstract] [Full Text] [Related]

  • 28. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 01; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 29. Targeting gene-virotherapy of cancer and its prosperity.
    Liu XY.
    Cell Res; 2006 Nov 01; 16(11):879-86. PubMed ID: 17102812
    [Abstract] [Full Text] [Related]

  • 30. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 31. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 01; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 32. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 01; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 33. A double-regulated oncolytic adenovirus with improved safety for adenocarcinoma therapy.
    Wei N, Fan JK, Gu JF, He LF, Tang WH, Cao X, Liu XY.
    Biochem Biophys Res Commun; 2009 Oct 16; 388(2):234-9. PubMed ID: 19653996
    [Abstract] [Full Text] [Related]

  • 34. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L, Chen D, Gong M, Na M, Li L, Wu H, Jiang L, Qian Y, Fang G, Xue X.
    Cancer Lett; 2009 Nov 01; 284(2):141-8. PubMed ID: 19447545
    [Abstract] [Full Text] [Related]

  • 35. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
    Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu XY.
    Acta Oncol; 2010 Nov 01; 49(1):91-9. PubMed ID: 19734998
    [Abstract] [Full Text] [Related]

  • 36. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC, Wang Y, Hallden G, Brooks G, Francis J, Lemoine NR, Kirn D.
    Gene Ther; 2005 Sep 01; 12(17):1333-46. PubMed ID: 15920462
    [Abstract] [Full Text] [Related]

  • 37. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
    Pan Q, Liu B, Liu J, Cai R, Liu X, Qian C.
    Acta Oncol; 2008 Sep 01; 47(1):135-44. PubMed ID: 17934893
    [Abstract] [Full Text] [Related]

  • 38. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect.
    Kim J, Kim PH, Yoo JY, Yoon AR, Choi HJ, Seong J, Kim IW, Kim JH, Yun CO.
    Gene Ther; 2009 Sep 01; 16(9):1111-21. PubMed ID: 19494843
    [Abstract] [Full Text] [Related]

  • 39. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC, Fang B.
    Clin Cancer Res; 2004 May 15; 10(10):3535-41. PubMed ID: 15161713
    [Abstract] [Full Text] [Related]

  • 40. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
    Ohashi M, Kanai F, Tateishi K, Taniguchi H, Marignani PA, Yoshida Y, Shiratori Y, Hamada H, Omata M.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):529-35. PubMed ID: 11401492
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.